Filing Details
- Accession Number:
- 0001225208-23-010042
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-07 16:11:20
- Reporting Period:
- 2023-11-06
- Accepted Time:
- 2023-11-07 16:11:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1533022 | F Michael Mahoney | 300 Boston Scientific Way Marlborough MA 01752-1234 | Chairman, President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-06 | 57,681 | $13.08 | 1,556,603 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-11-06 | 55,675 | $16.31 | 1,612,278 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-11-06 | 113,356 | $52.51 | 1,498,922 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-11-06 | 55,675 | $0.00 | 55,675 | $16.31 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-11-06 | 57,681 | $0.00 | 57,681 | $13.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 167,026 | 2025-02-23 | No | 4 | M | Direct | |
| 0 | 2024-02-24 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 176,245 | Indirect | By Trust |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 24, 2023, intended to comply with the prior version of Rule 10b5-1(c).
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $52.17 to $52.68, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
Billionaire Hedge Funds
